PDCD1 and cancer: Modified CAR T cells were deficient in two genes encoding TCR, namely TCRα and TCRβ and PD1 to restrict T cell exhaustion and increase antitumor efficacy and safety, thereby facilitating the expression of cancer specific TCR transgene (NY-ESO-1).